Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2556091 | 0.80 | — | — | |
| SCHEMBL2554916 | 0.77 | APP (0.31) | APP | |
| SCHEMBL24136312 | 0.71 | APP (0.33) | APP | |
| SCHEMBL3342370 | 0.70 | APP (0.35) | APP | |
| SCHEMBL28767331 | 0.70 | EPHX2 (0.33) | APP | |
| Phosphonic Acid SCHEMBL2559969 | 0.70 | — | — | |
| SCHEMBL2556908 | 0.70 | — | — | |
| SCHEMBL2876581 | 0.70 | APP (0.38) | APP | |
| SCHEMBL1931016 | 0.70 | — | — | |
| SCHEMBL2555664 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180346804-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | HERCULES LLC | 2018-12-06 | — | — | US | claimed |
| EP-3377034-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | Hercules LLC (US) | 2018-09-26 | — | — | EP | claimed |
| US-9493598-B2 | Polymers having acid and amide moieties, and uses thereof | ISP INVESTMENTS LLC (US) | 2016-11-15 | — | — | US | claimed |
| US-20130123147-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-05-16 | — | — | US | claimed |
| WO-2011130370-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-10-20 | — | — | WO | claimed |
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | HERCULES LLC (US) | 2021-05-11 | — | — | US | disclosed |
| US-20180346804-A1 | CROSSLINKED POLYMERS DERIVED FROM MONOMERS HAVING ACRYLOYL AND LACTAM MOIETIES AND SULFONIC ACID/SULFONATE COMONOMERS, COMPOSITIONS THEREOF, AND APPLICATIONS THEREOF | HERCULES LLC | 2018-12-06 | — | — | US | disclosed |
| US-9493598-B2 | Polymers having acid and amide moieties, and uses thereof | ISP INVESTMENTS LLC (US) | 2016-11-15 | — | — | US | disclosed |
| US-20130123147-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2013-05-16 | — | — | US | disclosed |
| WO-2011130370-A1 | POLYMERS HAVING ACID AND AMIDE MOIETIES, AND USES THEREOF | ISP INVESTMENTS INC. (US) | 2011-10-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11001751-B2 | Crosslinked polymers derived from monomers having acryloyl and lactam moieties and sulfonic acid/sulfonate comonomers, compositions thereof, and applications thereof | CAD, STS, COASY | APP 126/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.